We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
2Hayflick, SJ, Westaway, SK, Levinson, B, et al.Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003; 348(1): 33–40.Google Scholar
3
3Schneider, SA, Hardy, J, Bhatia, KP.Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord. 2012; 27(1): 42–53.Google Scholar
4
4Gregory, A, Hayflick, SJ.Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep. 2011; 11(3): 254–61.CrossRefGoogle ScholarPubMed
5
5Kruer, MC, Boddaert, N, Schneider, SA, et al.Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol. 2011; Sep 15 as 10.3174/ajnr.A2677 [Epub ahead of print].Google Scholar
6
6Kurian, MA, McNeill, A, Lin, JP, Maher, ER.Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol. 2011; 53(5): 394–404.Google Scholar
7
7Birbes, H, Bawab, SE, Obeid, LM, Hannun, YA.Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Advan Enzyme Regul. 2002; 42: 113–29.Google Scholar
8
8Bras, J, Singleton, A, Cookson, MR, Hardy, J.Emerging pathways in genetic Parkinson’s disease: potential role of ceramide metabolism in Lewy body disease. FEBS J.2008; 275(23): 5767–73.Google Scholar